<DOC>
	<DOCNO>NCT00006231</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . It yet know radiation therapy effective preventing metastatic cancer follow surgery . PURPOSE : Randomized phase III trial determine effectiveness radiation therapy prevent metastatic cancer patient undergone diagnostic procedure identify malignant mesothelioma .</brief_summary>
	<brief_title>Radiation Therapy Preventing Metastatic Cancer Patients Who Have Diagnostic Procedures Identify Malignant Mesothelioma</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy radiotherapy prevention metastatic skin nodule tumor seed follow invasive diagnostic procedure , chest drain insertion , pleural aspiration , pleural biopsy , thoracoscopy , patient malignant mesothelioma . - Determine whether nodule develop radiotherapy symptomatic patient . - Compare quality life patient treat radiotherapy v standard care alone . OUTLINE : This randomize study . Patients randomize 1 2 treatment arm . - Arm I : Patients receive radiotherapy 3 consecutive day begin within 3 week chest drain insertion , pleural aspiration , pleural biopsy , thoracoscopy wound heal . - Arm II : Patients receive standard supportive care alone . Quality life assess baseline , 1 , 2 , 4 , 6 , 9 , 12 month . Patients follow 1 , 2 , 4 , 6 , 9 , 12 month . PROJECTED ACCRUAL : A total 44 patient ( 22 per arm ) accrue study within 2 year .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove malignant pleural mesothelioma chest drain insertion , pleural aspiration , pleural biopsy , and/or thoracoscopy within past 3 week PATIENT CHARACTERISTICS : Age : Not specify Performance status : Not specify Life expectancy : At least 3 month Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior systemic chemotherapy malignant mesothelioma Endocrine therapy : Not specify Radiotherapy : No prior local radiotherapy malignant mesothelioma Surgery : See Disease Characteristics No invasive procedure chest site 1 year study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2000</verification_date>
	<keyword>localize malignant mesothelioma</keyword>
	<keyword>advanced malignant mesothelioma</keyword>
	<keyword>perioperative/postoperative complication</keyword>
</DOC>